The following is attributed to Commissioner of Food and Drugs - Food and Drug Administration, Stephen M. Hahn, M.D. Every step we have taken as part of our approach to COVID-19 testing has been a careful balancing of risks and benefits in order to meet the urgent public health needs as we combat this new pathogen. We have moved quickly and thoughtfully, and we are continuing … [Read more...] about Coronavirus (COVID-19) Update: Serological Test Validation and Education Efforts
Coronavirus
Italian Researchers Identify New SARS-CoV-2 Gene Variants That Provide Clues to Coronavirus’s Epidemiology
Scientists say early data, generated with new NGS research panel from Thermo Fisher Scientific, suggest coronavirus is genetically stable, and could increase the effectiveness of vaccines in development Two teams of infectious disease researchers in Italy say they have further analyzed the SARS-CoV-2 genome from samples acquired locally to generate early data that reveal a … [Read more...] about Italian Researchers Identify New SARS-CoV-2 Gene Variants That Provide Clues to Coronavirus’s Epidemiology
Over 50,000 visitors turn to virtual exhibition platform, a safe alternative to live physical shows amidst spread of Coronavirus
Operators of the V-Ex virtual exhibition platform have confirmed that over 50,000 people have recently visited online digital trade shows, sales environments and conferences. The unfortunate spread of Coronavirus has resulted in many exhibitors and visitors seeking a safe alternative to live physical shows. "Large corporations and some progressive exhibition businesses were … [Read more...] about Over 50,000 visitors turn to virtual exhibition platform, a safe alternative to live physical shows amidst spread of Coronavirus
Coronavirus (COVID-19) Update: White House Press Briefing by FDA Commissioner Stephen M. Hahn, M.D
Thank you for joining me today to provide updated information about the current state of diagnostic testing during this coronavirus public health emergency. First, I want to thank the dedicated professionals of the FDA for their round the clock, multi-layered approach to the coronavirus outbreak. I'd also like to thank our partners from across the federal government, such as … [Read more...] about Coronavirus (COVID-19) Update: White House Press Briefing by FDA Commissioner Stephen M. Hahn, M.D
Clover Successfully Produced 2019-nCoV Subunit Vaccine Candidate and Detected Cross-Reacting Antibodies from Sera of Multiple Infected Patients
Clover Biopharmaceuticals, a global clinical-stage biotechnology company focused on developing novel and transformative biologic therapies, announced today that it has successfully produced its trimeric Spike-protein (“S-Trimer”) subunit vaccine candidate for 2019-nCoV via a mammalian cell expression system. In addition, Clover scientists have used the newly obtained S-Trimer … [Read more...] about Clover Successfully Produced 2019-nCoV Subunit Vaccine Candidate and Detected Cross-Reacting Antibodies from Sera of Multiple Infected Patients
Novacyt S.A.: Update on Novel Coronavirus Test
Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT) ("Novacyt", the "Company" or the “Group”), an international specialist in clinical diagnostics, provides an update following the launch of its research use only (RUO) test for novel coronavirus (2019-nCoV), which has been developed by its subsidiary Primerdesign as a direct response to the recent outbreak of the respiratory virus in … [Read more...] about Novacyt S.A.: Update on Novel Coronavirus Test
FDA Takes Significant Step in Coronavirus Response Efforts, Issues Emergency Use Authorization for the First 2019 Novel Coronavirus Diagnostic
Today, the U.S Food and Drug Administration issued an emergency use authorization (EUA) to enable emergency use of the Centers for Disease Control and Prevention’s (CDC) 2019-nCoV Real-Time RT-PCR Diagnostic Panel. To date, this test has been limited to use at CDC laboratories; today’s authorization allows the use of the test at any CDC-qualified lab across the country. “Since … [Read more...] about FDA Takes Significant Step in Coronavirus Response Efforts, Issues Emergency Use Authorization for the First 2019 Novel Coronavirus Diagnostic
Clover Initiates Development of Recombinant Subunit-Trimer Vaccine for Wuhan Coronavirus (2019-nCoV)
Clover Biopharmaceuticals, a global clinical-stage biotechnology company focused on developing novel and transformative biologic therapies, today announced that it has initiated development of a recombinant subunit vaccine for 2019-nCoV, the newly identified coronavirus that is believed to have originated from Wuhan, China. Since this outbreak was first reported in late-2019, … [Read more...] about Clover Initiates Development of Recombinant Subunit-Trimer Vaccine for Wuhan Coronavirus (2019-nCoV)
CytoSorb, the Wuhan Coronavirus, and Cytokine Storm
MONMOUTH JUNCTION, N.J., Jan. 28, 2020 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader with more than 80,000 global treatments of its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, highlights the recent publication in The Lancet entitled, … [Read more...] about CytoSorb, the Wuhan Coronavirus, and Cytokine Storm
XJTLU Researcher Adding Piece To Puzzle Of New Coronavirus
According to a researcher at Xi'an Jiaotong-Liverpool University, the Wuhan coronavirus, nCoV-2019, is closely related to SARS from the viewpoint of virus evolution. "Our findings suggest the nCoV-2019 lineage is related to the bat coronaviruses that gave rise to SARS," said Dr Xiaowei Jiang, bioinformatics lecturer at XJTLU's Department of Biological Sciences. "As SARS was … [Read more...] about XJTLU Researcher Adding Piece To Puzzle Of New Coronavirus